145 related articles for article (PubMed ID: 23328975)
1. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
[TBL] [Abstract][Full Text] [Related]
2. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
Turcan D; Acikalin MF; Yilmaz E; Canaz F; Arik D
Pathol Res Pract; 2017 Jul; 213(7):831-835. PubMed ID: 28554748
[TBL] [Abstract][Full Text] [Related]
4. PAX2: a reliable marker for nephrogenic adenoma.
Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
[TBL] [Abstract][Full Text] [Related]
5. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation.
Karafin M; Parwani AV; Netto GJ; Illei PB; Epstein JI; Ladanyi M; Argani P
Am J Surg Pathol; 2011 Sep; 35(9):1264-73. PubMed ID: 21836481
[TBL] [Abstract][Full Text] [Related]
6. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
Hansel DE; Nadasdy T; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
[TBL] [Abstract][Full Text] [Related]
7. Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and Morphology.
Li L; Williamson SR; Castillo RP; Delma KS; Gonzalgo ML; Epstein JI; Kryvenko ON
Am J Surg Pathol; 2023 Jan; 47(1):37-46. PubMed ID: 36395466
[TBL] [Abstract][Full Text] [Related]
8. [Pathological and immunohistochemical analyses of 32 cases of nephrogenic adenoma].
Shen Q; Sun LH; Wang JH; Liu LB; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):522-6. PubMed ID: 23939154
[TBL] [Abstract][Full Text] [Related]
9. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
Legesse T; Matoso A; Epstein JI
Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic adenoma of the urinary tract: a review.
Alexiev BA; LeVea CM
Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
[TBL] [Abstract][Full Text] [Related]
11. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
[TBL] [Abstract][Full Text] [Related]
12. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms.
Butler RT; Alderman MA; Thompson LD; McHugh JB
Head Neck Pathol; 2015 Mar; 9(1):47-50. PubMed ID: 24771139
[TBL] [Abstract][Full Text] [Related]
14. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.
Herlitz LC; Tong GX; Hamele-Bena D; Greenebaum E
Diagn Cytopathol; 2008 Jan; 36(1):47-9. PubMed ID: 18064687
[TBL] [Abstract][Full Text] [Related]
17. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
18. A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall.
McDaniel AS; Palanisamy N; Smith SC; Robinson DR; Wu YM; Chinnaiyan AM; McHugh JB; Greenson JK; Kunju LP
Histol Histopathol; 2016 Feb; 31(2):223-30. PubMed ID: 26404914
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.
López JI; Schiavo-Lena M; Corominas-Cishek A; Yagüe A; Bauleth K; Guarch R; Hes O; Tardanico R
Virchows Arch; 2013 Dec; 463(6):819-25. PubMed ID: 24142157
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases.
Kao CS; Kum JB; Fan R; Grignon DJ; Eble JN; Idrees MT
Pediatr Dev Pathol; 2013; 16(2):80-5. PubMed ID: 23597251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
